ARL2 and liver cancer: For example, the study of Zilin Li et al. pointed out that in liver cancer cells with incomplete radiofrequency ablation, the expression of GAS6-DT is often up-regulated and can competitively inhibit the binding of microRNA-3619-5p to ARL2, thereby promoting the proliferation and migration of liver cancer cells (Li et al., 2021b).